Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    22056381 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes
Conditions: Skin Cancer;   Metastatic Melanoma
Interventions: Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: IL-12 transduced TIL

Indicates status has not been verified in more than two years